An antibody against the "don't eat me" signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.
Stanford researchers have discovered a compound that reduces the symptoms of heart failure after a heart attack in initial animal tests.
A Stanford professor unpacks some of the dynamics of the current drug pricing system and the potential effects of other approaches to this market.
Stanford chemists have developed a potential new strategy for fighting antibiotic-resistant bacterium — adding a new molecule onto an existing antibiotic.
Stanford researchers have identified a small molecule that may help curb some of the symptoms of a genetic deficiency in glucose-6-phosphate dehydrogenase.
As someone who had spent her career studying molecules on a computer screen, experiments involving people were a revelation and inspiration for Jane Tseng, PhD, …
One person’s weed is another’s flower. A good example of this is spiral-tufted bryozoan, an invasive marine organism that fouls up marine environments. Although considered …
After her team developed a compound with the potential to reduce the effects of heart attacks, Daria Mochly-Rosen, PhD, a professor of chemical and systems …
Researchers in the lab of Vijay Pande, PhD, have developed an algorithm to help make predictions about the properties of molecules. This algorithm could be …
